Bluebird Bio (NQ: BLUE )
0.6887
+0.0117
(+1.73%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Bluebird Bio
![](https://mms.businesswire.com/media/20210709005202/en/744394/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
![](https://g.foolcdn.com/editorial/images/631738/gettyimages-904794342.jpg)
![](https://g.foolcdn.com/editorial/images/630430/biotechlab.jpg)
![](https://mms.businesswire.com/media/20210611005056/en/1115286/4/2021-05-10-ksf-logo-sec-200.jpg)
![](https://mms.businesswire.com/media/20210611005081/en/741159/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
![](https://g.foolcdn.com/editorial/images/629908/gettyimages-1175270464.jpg)
![](https://mms.businesswire.com/media/20210607005708/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
From bluebird bio, Inc.
Via Business Wire
![](https://www.investors.com/wp-content/uploads/2021/03/Stock-BluebirdBio-01-shut.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_601.png)
FDA Gives Signal to Halted Bluebird Bio's Gene Therapy Trials In Sickle Cell Disease, Thalassemia
June 07, 2021
Via Benzinga
Exposures
Product Safety
![](https://mms.businesswire.com/media/20210607005267/en/744394/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/testeing.highres.national-cancer-institute-xknubmnjbkg-unsplash_copy.jpg)
![](https://mms.businesswire.com/media/20210602006012/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
![](https://g.foolcdn.com/editorial/images/628098/gettyimages-1164556175.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_422.png)
![](https://mms.businesswire.com/media/20210521005242/en/744394/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
![](https://mms.businesswire.com/media/20210519005693/en/791265/5/BMS_BluBird.jpg)
![](https://mms.businesswire.com/media/20210513005568/en/744394/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
![](https://mms.businesswire.com/media/20210505006054/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
![](https://mms.businesswire.com/media/20210503005391/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
![](https://g.foolcdn.com/editorial/images/621603/what_investors_need_to_know_about_this_419500_car_t_cancer_treatment1.jpg)
![](https://g.foolcdn.com/editorial/images/623400/female-and-male-technicians-study-samples-and-images-in-a-lab.jpg)
![](https://mms.businesswire.com/media/20210420005511/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
![](https://g.foolcdn.com/editorial/images/621030/is_bluebird_bio_a_bad_news_buy1.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Via NewMediaWire
Topics
Lawsuit
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Via NewMediaWire
Topics
Lawsuit
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Via NewMediaWire
Topics
Lawsuit
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.